Liang Liu MASTER OF SCIENCE (Tianjin University); DOCTOR OF PHILOSOPHY (University of Missouri Columbia); BACHELOR OF SCIENCE (Tianjin University)
Associate Professor , Wake Forest University, Winston-Salem, North Carolina · united states
Editorial leadership for Journal of Bioinformatics And Diabetes ISSN 2374-9431
Research interests
- Biophysics
- Bioinformatics
- Computational Biology
- Biostatistics
- Ngs (Next-Generation Sequencing) Data Analysis
- Bioinformatics Tool Development
- Molecular Modeling
- Structure Prediction
- Medical Physics
- Radiation Oncology
Biography
Liang Liu, MSc, PhD, BSc, is an Associate Professor at Wake Forest University in Winston-Salem, North Carolina, United States. He earned his BSc in Applied Physics from Tianjin University, China, followed by an MSc in Theoretical Physics from the same institution, and completed his PhD in Biophysics at the University of Missouri, Columbia, where his doctoral research focused on physics-based predictions of RNA stability and structures. Dr. Liu has authored over 19 indexed publications, with his most-cited work examining IGFBP2-mediated tumor progression through macrophage polarization in pancreatic ductal adenocarcinoma via the STAT3 pathway, accumulating 79 citations since its 2021 publication. His research integrates theoretical physics and biophysics approaches to address problems in molecular biology and cancer biology.
Selected publications
- IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway 2021 cited 79×
- IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma 2020 cited 69×
- Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer 2021 cited 57×
- SMARCA4 mutations in KRAS ‐mutant lung adenocarcinoma: a multi‐cohort analysis 2020 cited 56×
- Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1 2018 cited 27×
- Targeting ABCD1-ACOX1-MET/IGF1R axis suppresses multiple myeloma Recent 2025 cited 6×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBD for your work?
This journal is guided by Liang Liu (Associate Professor , Wake Forest University, Winston-Salem, North Carolina) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.